Stay updated on Pembrolizumab and Olaparib in BRCA Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Olaparib in BRCA Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Olaparib in BRCA Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Site revision label updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:33:13.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    The revision history is updated to include v3.5.0 as the latest revision and removes v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T04:48:50.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page revision label was updated to v3.4.3, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T00:29:09.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    The study status was updated to Completed with actual completion dates, replacing the previous 'Active, not recruiting' status. The page revision was updated to v3.4.2 and the funding-status notice was removed.
    Difference
    0.8%
    Check dated 2026-02-11T11:43:11.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    A government funding status notice banner was added and the site revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:23:06.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Glossary toggle added; a new label 'Last Update Submitted that Met QC Criteria' appears and a 'No FEAR Act Data' notice is shown. The site revision is updated from v3.3.4 to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T05:56:22.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Olaparib in BRCA Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Olaparib in BRCA Breast Cancer Clinical Trial page.